TIMP3 and head and neck squamous cell carcinoma: In a hypothesis-driven approach, we determined the expression levels of TACE and TIMP3 mRNA by in situ hybridisation in a training set comprising a series of commercially supplied histopathologically defined HNSCC specimens (HNSCC tissue micro array; US Biomax, Inc., Rockville, MD, USA).